Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
320.4 DKK | 0.00% | -1.42% | +8.24% |
May. 06 | DEMANT : Q1 sales miss; organic growth guidance unchanged | |
May. 06 | Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024 |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- With an enterprise value anticipated at 3.56 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+8.24% | 10.08B | B- | ||
-1.49% | 17.54B | A | ||
+7.25% | 13.95B | B | ||
-8.16% | 2.23B | - | ||
+5.65% | 1.79B | B+ | ||
+33.51% | 1.71B | D- | ||
+20.00% | 643M | - | ||
0.00% | 389M | - | - | |
+38.10% | 154M | - | ||
+20.48% | 87.55M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- DEMANT Stock
- Ratings Demant A/S